Surgery for Obesity and Related Diseases is an esteemed scholarly journal published by ELSEVIER SCIENCE INC, focusing on cutting-edge research and advancements in the field of obesity surgery. With an impressive impact factor and ranking in the 94th percentile among its peers in Medicine and Surgery, this journal maintains a prestigious position in the Q1 category of surgical studies. Since its inception in 2005, it has served as a vital platform for disseminating original research, clinical studies, and reviews that aim to improve patient outcomes and deepen our understanding of obesity-related diseases. The journal facilitates a wide array of access options, ensuring that professionals, researchers, and students across the globe can engage with current findings and best practices in surgical and medical treatment of obesity. As we look toward 2024 and beyond, Surgery for Obesity and Related Diseases remains committed to fostering innovation in surgical techniques and interdisciplinary approaches to solving one of the most pressing health challenges of our time.

The Journal of Obesity & Metabolic Syndrome, published by the Korean Society for the Study of Obesity, is a premier, open access journal that has been championing research in the realms of endocrinology, diabetes, and metabolism since its inception in 2012. With an ISSN of 2508-6235 and an E-ISSN of 2508-7576, this journal has quickly established itself as a leading publication, currently ranked in the Q1 category within its field and occupying the 46th position out of 244 in Scopus' Medicine category, with an impressive 81st percentile ranking. The journal serves as a vital platform for disseminating high-quality research and innovative findings related to obesity and metabolic disorders, fostering collaboration among researchers, healthcare professionals, and students dedicated to advancing knowledge and treatment strategies. For those interested in contributing or gaining access to cutting-edge research, the journal emphasizes its commitment to open access principles by providing unrestricted access to its content, thereby enhancing the visibility and impact of studies within the global scientific community.

Metabolic Syndrome and Related Disorders is an esteemed journal published by MARY ANN LIEBERT, INC, focusing on the multifaceted aspects of metabolic syndrome, including its interaction with chronic diseases such as diabetes, cardiovascular conditions, and obesity. Since its inception in 2003, this journal has established itself as a vital resource for researchers, healthcare professionals, and students dedicated to advancing knowledge in the fields of endocrinology, internal medicine, and metabolic disorders. With an impact factor reflective of its academic significance, Metabolic Syndrome and Related Disorders is recognized within the Q2 and Q3 quartiles in its respective categories, solidifying its reputation among scientific and clinical communities. Although it does not currently offer open access options, the journal remains committed to disseminating high-quality research and reviews that foster innovative solutions and improve patient outcomes. The journal's gradual convergence towards 2024 presents an exciting opportunity for continued exploration and dialogue about metabolic-related health challenges.

DIABETES OBESITY & METABOLISM, published by Wiley, is a premier international journal dedicated to the fields of endocrinology, diabetes, and metabolic disorders. With an impressive impact factor and its status as a Q1 journal in multiple categories—including Endocrinology and Internal Medicine—this publication is highly regarded in the academic community. Since its inception in 1999, the journal has served as a crucial platform for the dissemination of cutting-edge research, reviews, and clinical studies, driving advancements in understanding and treatment of diabetes and obesity. Researchers and professionals alike benefit from its rigorous peer-review process and extensive reach, as it aims to bridge the gap between laboratory findings and clinical applications. Although not an Open Access journal, articles are accessible through institutional subscriptions, ensuring that vital knowledge reaches those committed to enhancing patient care and expanding the scientific body of work in these pivotal areas.

The Journal of Obesity, published by HINDAWI LTD, stands at the forefront of research in the field of Endocrinology, Diabetes and Metabolism, providing a vital platform for the dissemination of knowledge and advancements in obesity research. With an impact factor that reflects its significance in the academic community—holding a prestigious Q2 ranking in its category—the journal has continuously evolved since its establishment as an Open Access publication in 2010, promoting unrestricted access to high-quality research. Operating from Egypt, the journal focuses on disseminating impactful studies that address the global epidemic of obesity, making a meaningful contribution to public health solutions. Researchers, professionals, and students in the related fields will find valuable insights and innovative findings within its pages, as the journal endeavors to bridge the gap between scientific research and practical application. As of 2023, it occupies a notable position, ranked #58 out of 244 in Scopus, showcasing its commitment to excellence and relevance in the rapidly evolving landscape of obesity research.

Obesity Science & Practice is a prestigious, peer-reviewed journal dedicated to advancing knowledge and research in the fields of obesity, endocrinology, diabetes, metabolism, and nutrition. Published by Wiley, this journal has established itself as a vital resource for researchers, healthcare professionals, and students interested in the latest evidence-based practices and innovations in obesity management. With an impact factor that reflects its significance, and ranked in the Q2 category for both Endocrinology, Diabetes and Metabolism, and Nutrition and Dietetics in 2023, the journal aims to foster interdisciplinary collaboration and dissemination of cutting-edge research. Since its transition to Open Access in 2015, Obesity Science & Practice has become increasingly accessible, emphasizing the importance of making research findings available to a wider audience. This convergence of expertise and commitment to public health makes the journal an essential forum for advancing scholarship and practice in tackling widespread global health challenges.

Obesity is a premier academic journal published by WILEY, dedicated to advancing knowledge in the fields of endocrinology, nutrition, and metabolism. With an impressive impact factor and ranking in the top quartile across multiple categories, including Q1 in Endocrinology, Diabetes and Metabolism, and Nutrition and Dietetics, this journal serves as a critical resource for researchers, clinicians, and policymakers. The journal facilitates the dissemination of innovative research findings spanning the biological, behavioral, and societal factors associated with obesity, offering Open Access options to ensure broad visibility and accessibility to its content. With converged years from 2006 to 2024, Obesity provides an invaluable platform for cutting-edge studies that contribute to the global understanding of obesity and its multifaceted implications for health and wellness. Located in Hoboken, New Jersey, this esteemed journal plays a pivotal role in shaping the dialogue around obesity, making it an essential read for anyone invested in tackling this pressing public health challenge.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, published by Springer, is a leading journal in the field of endocrinology, diabetes, and metabolism, with an impressive Q1 ranking in both categories as of 2023. With an ISSN of 1389-9155 and E-ISSN 1573-2606, this journal serves as a vital resource for researchers, clinicians, and students seeking comprehensive reviews that address the latest advancements and interdisciplinary approaches in the management of endocrine and metabolic disorders. Operating from the Netherlands, it features articles that are rigorously peer-reviewed and is notable for its significant impact factor reflected in its Scopus rankings, placing it in the top percentile of its categories. Although it does not currently offer open access, it provides critical insights applicable to both basic and clinical settings, making it indispensable for those dedicated to enhancing patient outcomes in endocrine health.

Expert Review of Endocrinology & Metabolism is a premier journal dedicated to advancing the field of endocrinology and metabolism, published by Routledge Journals, Taylor & Francis Ltd, in the United Kingdom. With a robust focus on the latest research, innovative treatments, and clinical practices, this journal serves as an essential resource for healthcare professionals, researchers, and students seeking to stay abreast of developments in diabetes, obesity, thyroid disorders, and other endocrine-related conditions. Achieving a commendable Q2 status in Endocrinology, Diabetes, and Metabolism in the 2023 ranking, Expert Review of Endocrinology & Metabolism holds strong standing with an impressive Scopus rank, placing it at the 53rd percentile among its peers. The journal embraces a comprehensive approach, offering critical reviews, original research articles, and insights on emerging trends and technologies in the field. Although not an open-access journal, it provides extensive access options for subscribers and institutions, encouraging ease of dissemination and academic engagement. Through its commitment to high-quality content, Expert Review of Endocrinology & Metabolism remains pivotal for professionals aiming to enhance their understanding and practice in this vital area of medicine.

The International Journal of Endocrinology is a premier peer-reviewed journal, published by HINDAWI LTD, focusing on the rapidly evolving fields of endocrinology, diabetes, and metabolism. Since its establishment in 2009, the journal has embraced an Open Access model, ensuring that cutting-edge research is accessible to a global audience without barriers. With an impressive Scopus rank placing it within the top quartiles of related fields, it ranks #103 in Endocrinology, Diabetes and Metabolism, showcasing its significant contribution to the ongoing discourse in these areas. The journal's scope includes original research, reviews, and clinical studies that advance understanding and treatment strategies for endocrine disorders. By bridging the gap between research, clinical practice, and patient care, the International Journal of Endocrinology serves as an essential resource for researchers, practitioners, and students dedicated to the field of endocrinology. Addressed from its headquarters in the United States, this journal not only contributes to academic advancement but also fosters international collaboration in addressing key challenges in endocrinology.